Aldossary Mohammed S, Mufrrih Mohammed, El Dalatony Mervat M, Alamri Hatoon M
General Directorate of Research and Studies, Ministry of Health, Riyadh, Saudi Arabia.
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Front Public Health. 2025 May 15;13:1580699. doi: 10.3389/fpubh.2025.1580699. eCollection 2025.
Human Papillomavirus (HPV) is a prevalent sexually transmitted infection that can lead to benign lesions, premalignant changes, and cancer. Despite its significance, studies in Saudi Arabia report inconsistent findings regarding HPV prevalence and risk factors. This systematic review and meta-analysis aimed to assess the prevalence and genotype distribution of HPV among women in Saudi Arabia.
A systematic literature search was conducted across multiple electronic databases (January 1990-August 2024). Studies reporting HPV prevalence among women in Saudi Arabia, regardless of nationality or health status, were included. The pooled prevalence was calculated using a random-effects model, with log-transformed proportions and 95% confidence intervals (CI).
Twenty-two studies ( = 15,224 women) met the inclusion criteria. The pooled prevalence of HPV among women attending cervical screening was 14.9% (95% CI: 10.9-18.9%), with substantial heterogeneity (I = 97.4%, < 0.001). Subgroup analysis by region showed a higher prevalence in Riyadh (19.1, 95% CI: 13.1-25%) compared to the Western region (6.1, 95% CI: 3.7-8.4%). Among women with gynecological malignancies, the pooled prevalence was 68.1% (95% CI: 49-87.1%). HPV-16 was the most common genotype (35.4%), followed by HPV-18 (10.9%). Other high-risk types (HPV-45, 31, 33, 35, 52, and 58) accounted for 2.2-13.7% of infections.
HPV prevalence in Saudi Arabia is comparable to global figures, though significant geographic variability exists. A national screening survey is necessary to establish the true prevalence and inform preventive strategies.
PROSPERO No. CRD42024583260.
人乳头瘤病毒(HPV)是一种常见的性传播感染,可导致良性病变、癌前病变和癌症。尽管其具有重要意义,但沙特阿拉伯的研究报告了关于HPV患病率和危险因素的不一致结果。本系统评价和荟萃分析旨在评估沙特阿拉伯女性中HPV的患病率和基因型分布。
在多个电子数据库(1990年1月至2024年8月)中进行了系统的文献检索。纳入了报告沙特阿拉伯女性中HPV患病率的研究,无论其国籍或健康状况如何。使用随机效应模型计算合并患病率,并对比例进行对数转换,同时给出95%置信区间(CI)。
22项研究(n = 15224名女性)符合纳入标准。参加宫颈筛查的女性中HPV的合并患病率为14.9%(95%CI:10.9 - 18.9%),存在显著异质性(I² = 97.4%,P < 0.001)。按地区进行的亚组分析显示,利雅得的患病率(19.1%,95%CI:13.1 - 25%)高于西部地区(6.1%,95%CI:3.7 - 8.4%)。在患有妇科恶性肿瘤的女性中,合并患病率为68.1%(95%CI:49 - 87.1%)。HPV - 16是最常见的基因型(35.4%),其次是HPV - 18(10.9%)。其他高危型(HPV - 45、31、33、35、52和58)占感染的2.2 - 13.7%。
沙特阿拉伯的HPV患病率与全球数据相当,但存在显著的地理差异。有必要进行全国性筛查调查,以确定真实患病率并为预防策略提供依据。
PROSPERO编号CRD42024583260。